UK markets open in 4 hours 28 minutes
NIKKEI 225
38,712.73 -234.20 (-0.60%) HANG SENG
19,350.60 +129.98 (+0.68%) CRUDE OIL
79.06 -0.20 (-0.25%) GOLD FUTURES
2,428.30 +2.40 (+0.10%) DOW
39,872.99 +66.22 (+0.17%) Bitcoin GBP
55,219.71 -586.21 (-1.05%)
Arcus Biosciences, Inc. (RCUS)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.53B |
| Enterprise value | 542.19M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 5.47 |
| Price/book (mrq) | 2.16 |
| Enterprise value/revenue | 2.29 |
| Enterprise value/EBITDA | 3.96 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.91 |
| 52-week change 3 | -4.49% |
| S&P500 52-week change 3 | 29.31% |
| 52-week high 3 | 25.47 |
| 52-week low 3 | 12.95 |
| 50-day moving average 3 | 16.68 |
| 200-day moving average 3 | 17.20 |
Share statistics
| Avg vol (3-month) 3 | 668.85k |
| Avg vol (10-day) 3 | 669.92k |
| Shares outstanding 5 | 90.95M |
| Implied shares outstanding 6 | 90.95M |
| Float 8 | 54.48M |
| % held by insiders 1 | 40.82% |
| % held by institutions 1 | 59.81% |
| Shares short (30 Apr 2024) 4 | 7.75M |
| Short ratio (30 Apr 2024) 4 | 14.22 |
| Short % of float (30 Apr 2024) 4 | 17.69% |
| Short % of shares outstanding (30 Apr 2024) 4 | 8.52% |
| Shares short (prior month 28 Mar 2024) 4 | 8.25M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -97.47% |
| Operating margin (ttm) | 2.76% |
Management effectiveness
| Return on assets (ttm) | -12.27% |
| Return on equity (ttm) | -35.35% |
Income statement
| Revenue (ttm) | 237M |
| Revenue per share (ttm) | 3.07 |
| Quarterly revenue growth (yoy) | 480.00% |
| Gross profit (ttm) | N/A |
| EBITDA | -241M |
| Net income avi to common (ttm) | -231M |
| Diluted EPS (ttm) | -3.11 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 995M |
| Total cash per share (mrq) | 10.94 |
| Total debt (mrq) | 139M |
| Total debt/equity (mrq) | 19.66% |
| Current ratio (mrq) | 5.22 |
| Book value per share (mrq) | 7.78 |
Cash flow statement
| Operating cash flow (ttm) | -210M |
| Levered free cash flow (ttm) | -93.5M |
© 2024 Yahoo. All rights reserved.